[{"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":12004000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":20668000.0,"EarningsPerShareDiluted_1_Q1_USD":0.01,"StockholdersEquity_0_Q1_USD":203712000.0,"RevenuesConverted_1_Q1_USD":54521000.0,"Assets_0_Q1_USD":463843000.0,"NetIncomeLossConverted_1_Q1_USD":81000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":12017000.0,"EarningsPerShareBasic_1_Q1_USD":0.01,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]